Saltar al contenido
Merck

Inhibition of DNA binding of Sox2 by the SUMO conjugation.

Biochemical and biophysical research communications (2006-11-14)
Shu Tsuruzoe, Ko Ishihara, Yasuhiro Uchimura, Sugiko Watanabe, Yoko Sekita, Takahiro Aoto, Hisato Saitoh, Yasuhito Yuasa, Hitoshi Niwa, Michio Kawasuji, Hideo Baba, Mitsuyoshi Nakao
RESUMEN

Sox2 is a member of the high mobility group (HMG) domain DNA-binding proteins for transcriptional control and chromatin architecture. The HMG domain of Sox2 binds the DNA to facilitate transactivation by the cooperative transcription factors such as Oct3/4. We report that mouse Sox2 is modified by SUMO at lysine 247. Substitution of the target lysine to arginine lost the sumoylation but little affected transcriptional potential or nuclear localization of Sox2. By contrast with the unmodified form, Sox2 fused to SUMO-1 did not augment transcription via the Fgf4 enhancer in the presence of Oct3/4. Further, SUMO-1-conjugated Sox2 at the lysine 247 or at the carboxyl terminus reduced the binding to the Fgf4 enhancer. These indicate that Sox2 sumoylation negatively regulates its transcriptional role through impairing the DNA binding.